IMMUPHARMA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.145 GBX | -1.61% |
|
-4.67% | +28.67% |
| 29/04 | Immunovia Announces the Appointment of Lisa Fordas as Clinical Laboratory Director | CI |
| 02/04 | Immupharma jumps amid new IP strategy for P140 technology platform | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 11.55M | - | - | - | - | - | |
| 62.59B | - | |||||
| 41.18B | ||||||
| 40.29B | ||||||
| 27.9B | ||||||
| 26.21B |
- Stock Market
- Equities
- IMM Stock
- Charts ImmuPharma plc
- Sector Chart
